<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>mergers Archives - UK Investor Magazine</title>
	<atom:link href="https://ukinvestor.foxrobinson.com/tag/mergers/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestor.foxrobinson.com/tag/mergers/</link>
	<description></description>
	<lastBuildDate>Wed, 13 Jan 2021 14:25:20 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.6.3</generator>
	<item>
		<title>Global M&#038;A activity soars 88% in H2 2020</title>
		<link>https://ukinvestor.foxrobinson.com/global-ma-activity-soars-88-in-h2-2020/</link>
					<comments>https://ukinvestor.foxrobinson.com/global-ma-activity-soars-88-in-h2-2020/#respond</comments>
		
		<dc:creator><![CDATA[Bronte Carvalho]]></dc:creator>
		<pubDate>Wed, 13 Jan 2021 14:25:18 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[2020]]></category>
		<category><![CDATA[acquisitions]]></category>
		<category><![CDATA[businesses]]></category>
		<category><![CDATA[Companies]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[m&a]]></category>
		<category><![CDATA[mergers]]></category>
		<category><![CDATA[mergers and acquisitions]]></category>
		<guid isPermaLink="false">https://ukinvestor.foxrobinson.com/?p=34309</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestor.foxrobinson.com/wp-content/uploads/2021/01/Global-MA-activity-soars-88-in-H2-2020-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" fetchpriority="high" srcset="https://ukinvestor.foxrobinson.com/wp-content/uploads/2021/01/Global-MA-activity-soars-88-in-H2-2020-300x200.jpg 300w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2021/01/Global-MA-activity-soars-88-in-H2-2020-768x512.jpg 768w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2021/01/Global-MA-activity-soars-88-in-H2-2020-150x100.jpg 150w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2021/01/Global-MA-activity-soars-88-in-H2-2020-600x400.jpg 600w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2021/01/Global-MA-activity-soars-88-in-H2-2020-696x464.jpg 696w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2021/01/Global-MA-activity-soars-88-in-H2-2020-630x420.jpg 630w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2021/01/Global-MA-activity-soars-88-in-H2-2020.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>Global mergers and acquisition (M&#38;A) activity soared by 88% to $2.3 trillion in H2 2020, amounting to the strongest second half in history and overtaking the previous record held by the 46% increase in H2 1997. H2 2020 was also the strongest second half in history in terms of deal value. According to the research [&#8230;]</p>
<p>The post <a href="https://ukinvestor.foxrobinson.com/global-ma-activity-soars-88-in-h2-2020/">Global M&amp;A activity soars 88% in H2 2020</a> appeared first on <a href="https://ukinvestor.foxrobinson.com">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestor.foxrobinson.com/global-ma-activity-soars-88-in-h2-2020/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>UK merger activity anticipated</title>
		<link>https://ukinvestor.foxrobinson.com/uk-merger-activity-anticipated/</link>
		
		<dc:creator><![CDATA[Andrew Hore]]></dc:creator>
		<pubDate>Sun, 15 Nov 2020 22:09:13 +0000</pubDate>
				<category><![CDATA[Premium]]></category>
		<category><![CDATA[Shares]]></category>
		<category><![CDATA[acquisitions]]></category>
		<category><![CDATA[LON:BLND]]></category>
		<category><![CDATA[LON:FDEV]]></category>
		<category><![CDATA[LON:GPOR]]></category>
		<category><![CDATA[LON:JSG]]></category>
		<category><![CDATA[LON:MCKS]]></category>
		<category><![CDATA[LON:RDI]]></category>
		<category><![CDATA[LON:SDX]]></category>
		<category><![CDATA[LON:SQZ]]></category>
		<category><![CDATA[LON:TM17]]></category>
		<category><![CDATA[LON:TPT]]></category>
		<category><![CDATA[LON:WEN]]></category>
		<category><![CDATA[mergers]]></category>
		<guid isPermaLink="false">https://ukinvestor.foxrobinson.com/?page_id=32656</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestor.foxrobinson.com/wp-content/uploads/2020/11/ESMA-warns-fund-managers-to-prepare-for-future-adverse-shocks-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" srcset="https://ukinvestor.foxrobinson.com/wp-content/uploads/2020/11/ESMA-warns-fund-managers-to-prepare-for-future-adverse-shocks-300x200.jpg 300w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2020/11/ESMA-warns-fund-managers-to-prepare-for-future-adverse-shocks-768x513.jpg 768w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2020/11/ESMA-warns-fund-managers-to-prepare-for-future-adverse-shocks-629x420.jpg 629w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2020/11/ESMA-warns-fund-managers-to-prepare-for-future-adverse-shocks-537x360.jpg 537w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2020/11/ESMA-warns-fund-managers-to-prepare-for-future-adverse-shocks-640x428.jpg 640w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2020/11/ESMA-warns-fund-managers-to-prepare-for-future-adverse-shocks-681x455.jpg 681w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2020/11/ESMA-warns-fund-managers-to-prepare-for-future-adverse-shocks.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>Broker Peel Hunt believes that the current level of bidding activity means that the market is undervalued. It thinks that the potential vaccine means that bidders will take a longer-term view and assuming talks with the EU do result in a trade deal that will remove further uncertainty. While AIM has outperformed most markets around [&#8230;]</p>
<p>The post <a href="https://ukinvestor.foxrobinson.com/uk-merger-activity-anticipated/">UK merger activity anticipated</a> appeared first on <a href="https://ukinvestor.foxrobinson.com">UK Investor Magazine</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Pharma M&#038;A deal value fell by more than 92% year-on-year</title>
		<link>https://ukinvestor.foxrobinson.com/pharma-ma-deal-value-fell-by-more-than-92-year-on-year/</link>
					<comments>https://ukinvestor.foxrobinson.com/pharma-ma-deal-value-fell-by-more-than-92-year-on-year/#comments</comments>
		
		<dc:creator><![CDATA[Jamie Gordon]]></dc:creator>
		<pubDate>Mon, 26 Oct 2020 14:16:03 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[acquisitions]]></category>
		<category><![CDATA[COVID]]></category>
		<category><![CDATA[deals]]></category>
		<category><![CDATA[life sciences]]></category>
		<category><![CDATA[m&a]]></category>
		<category><![CDATA[medical devices]]></category>
		<category><![CDATA[mergers]]></category>
		<category><![CDATA[pandemic]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[pharmaceuticals]]></category>
		<category><![CDATA[value]]></category>
		<guid isPermaLink="false">https://ukinvestor.foxrobinson.com/?p=32064</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestor.foxrobinson.com/wp-content/uploads/2020/10/Pharma-industry-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" srcset="https://ukinvestor.foxrobinson.com/wp-content/uploads/2020/10/Pharma-industry-300x200.jpg 300w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2020/10/Pharma-industry-768x512.jpg 768w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2020/10/Pharma-industry-630x420.jpg 630w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2020/10/Pharma-industry-537x360.jpg 537w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2020/10/Pharma-industry-640x427.jpg 640w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2020/10/Pharma-industry-681x454.jpg 681w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2020/10/Pharma-industry.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>According to data compiled by ComprarAcciones, M&#38;A deal activity in the pharma sector rose by 17% during the first half of 2020. To many, this would appear to be a positive shift, given the economic impacts of the pandemic. However, the rise in pharma industry deals might not come as a surprise to some, and [&#8230;]</p>
<p>The post <a href="https://ukinvestor.foxrobinson.com/pharma-ma-deal-value-fell-by-more-than-92-year-on-year/">Pharma M&amp;A deal value fell by more than 92% year-on-year</a> appeared first on <a href="https://ukinvestor.foxrobinson.com">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestor.foxrobinson.com/pharma-ma-deal-value-fell-by-more-than-92-year-on-year/feed/</wfw:commentRss>
			<slash:comments>2</slash:comments>
		
		
			</item>
	</channel>
</rss>
